August 22, 2025 · Form 4 insider transaction
ELITE PHARMACEUTICALS INC /NV/ sold 500,000 shares of ELITE PHARMACEUTICALS INC at $0.52 per share, a transaction worth $262.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.56, inclusive. The reporting person undertakes to provide to Elite Phannaceuticals, any security holder of Elite Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(1) to this Form 4